The hazards of hazard ratios.
作者信息
Hernán Miguel A
机构信息
Department of Epidemiology, Harvard School of Public Health, and the Harvard-MIT Division of Health Sciences and Technology, Boston, MA 02115, USA.
出版信息
Epidemiology. 2010 Jan;21(1):13-5. doi: 10.1097/EDE.0b013e3181c1ea43.
Abstract
摘要
相似文献
1
The hazards of hazard ratios.
Epidemiology. 2010 Jan;21(1):13-5. doi: 10.1097/EDE.0b013e3181c1ea43.
2
Hazard ratio bias in cohort studies.
Epidemiology. 2013 Sep;24(5):777-8. doi: 10.1097/EDE.0b013e31829f65a7.
3
[Cox regression analysis in epidemiological research].
G Ital Nefrol. 2011 May-Jun;28(3):319-22.
4
Regression standardization with the R package stdReg.
Eur J Epidemiol. 2016 Jun;31(6):563-74. doi: 10.1007/s10654-016-0157-3. Epub 2016 May 14.
5
An Assessment of the Cox Proportional Hazards Regression Model for Epidemiologic Studies.
Risk Anal. 2018 Apr;38(4):777-794. doi: 10.1111/risa.12865. Epub 2017 Nov 23.
6
Regression analysis.
Pract Neurol. 2007 Aug;7(4):259-64. doi: 10.1136/jnnp.2007.120055.
7
Conditional maximum likelihood estimation in semiparametric transformation model with LTRC data.
Lifetime Data Anal. 2018 Apr;24(2):250-272. doi: 10.1007/s10985-016-9385-9. Epub 2017 Feb 6.
8
Cox proportional hazards models have more statistical power than logistic regression models in cross-sectional genetic association studies.
Eur J Hum Genet. 2008 Sep;16(9):1111-6. doi: 10.1038/ejhg.2008.59. Epub 2008 Apr 2.
9
A regularized variable selection procedure in additive hazards model with stratified case-cohort design.
Lifetime Data Anal. 2018 Jul;24(3):443-463. doi: 10.1007/s10985-017-9402-7. Epub 2017 Jul 28.
10
Sequential tests for non-proportional hazards data.
Lifetime Data Anal. 2017 Jul;23(3):339-352. doi: 10.1007/s10985-016-9360-5. Epub 2016 Mar 11.
引用本文的文献
1
Vancomycin-Induced Acute Kidney Injury in Intensive Care Patients: A Target Trial Emulation Study Using Multicenter Routinely Collected Data.
Pharmacoepidemiol Drug Saf. 2025 Sep;34(9):e70205. doi: 10.1002/pds.70205.
2
Using Restricted Mean Time Lost to Evaluate the Prognostic Effects on Locally Advanced Breast Cancer Considering Competing Risks.
Clin Epidemiol. 2025 Aug 22;17:693-705. doi: 10.2147/CLEP.S521309. eCollection 2025.
3
A Review of Causal Inference Methods for Estimating the Effects of Exposure Change When Incident Exposure Is Unobservable.
Curr Epidemiol Rep. 2024 Dec;11(4):185-198. doi: 10.1007/s40471-024-00343-5. Epub 2024 Feb 19.
4
Plant-based dietary patterns and age-specific risk of multimorbidity of cancer and cardiometabolic diseases: a prospective analysis.
Lancet Healthy Longev. 2025 Aug;6(8):100742. doi: 10.1016/j.lanhl.2025.100742. Epub 2025 Aug 19.
5
The Effect of Incarceration on Mortality.
Rev Econ Stat. 2024 Jul;106(4):956-973. doi: 10.1162/rest_a_01224. Epub 2024 Jul 8.
6
Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.
EClinicalMedicine. 2025 Jul 30;86:103392. doi: 10.1016/j.eclinm.2025.103392. eCollection 2025 Aug.
7
Target Aggregate Data Adjustment Method for Transportability Analysis Utilizing Summary-Level Data From the Target Population.
Pharm Stat. 2025 Sep-Oct;24(5):e70029. doi: 10.1002/pst.70029.
8
Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population-Based Case-Control Study.
Cancer Med. 2025 Aug;14(15):e71110. doi: 10.1002/cam4.71110.
9
Trastuzumab in early curative breast cancer: A target trial emulation benchmarked against two randomized clinical trials.
PLoS Med. 2025 Jul 21;22(7):e1004661. doi: 10.1371/journal.pmed.1004661. eCollection 2025 Jul.
10
Analysis of follow-up data in large biobank cohorts: a review of methodology.
Front Genet. 2025 Jun 25;16:1534726. doi: 10.3389/fgene.2025.1534726. eCollection 2025.
本文引用的文献
1
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.
Ann Intern Med. 2010 Feb 16;152(4):211-7. doi: 10.7326/0003-4819-152-4-201002160-00005.
2
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States.
Clin J Am Soc Nephrol. 2009 Mar;4(3):638-44. doi: 10.2215/CJN.05071008. Epub 2009 Mar 4.
3
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
Epidemiology. 2008 Nov;19(6):766-79. doi: 10.1097/EDE.0b013e3181875e61.
4
Properties of 2 counterfactual effect definitions of a point exposure.
Epidemiology. 2007 Jul;18(4):453-60. doi: 10.1097/01.ede.0000261472.07150.4f.
5
Statistical issues arising in the Women's Health Initiative.
Biometrics. 2005 Dec;61(4):899-911; discussion 911-41. doi: 10.1111/j.0006-341X.2005.454_1.x.
6
Structural accelerated failure time models for survival analysis in studies with time-varying treatments.
Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):477-91. doi: 10.1002/pds.1064.
7
A structural approach to selection bias.
Epidemiology. 2004 Sep;15(5):615-25. doi: 10.1097/01.ede.0000135174.63482.43.
8
Adjusted survival curves with inverse probability weights.
Comput Methods Programs Biomed. 2004 Jul;75(1):45-9. doi: 10.1016/j.cmpb.2003.10.004.
9
Estrogen plus progestin and the risk of coronary heart disease.
N Engl J Med. 2003 Aug 7;349(6):523-34. doi: 10.1056/NEJMoa030808.
10
Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference.
Epidemiology. 1996 Sep;7(5):498-501.
Zotero 插件